Retatrutide

10 posts · started by Dubdoyle · Aug 1, 2025

👤
Dubdoyle
Junior Member
Posts: 12
Joined: May 2015
Rep: 10
👤
Dubdoyle
12 posts · joined May 2015
#1
Hi, I know Med-tech do not sell this or “skinny jabs” but does anyone have any experience with them? And anyone know a reputable source to purchase in the UK? Really struggling with appetite on my cut and any help I’ll gladly take!! Thank you
👤
DarrenW29
Senior Member
Posts: 1,651
Joined: Apr 2020
Rep: 89
👤
DarrenW29
1,651 posts · joined Apr 2020
#2
Yes please direct message me
👤
DarrenW29
Senior Member
Posts: 1,651
Joined: Apr 2020
Rep: 89
👤
DarrenW29
1,651 posts · joined Apr 2020
#3
Thanks for keeping loyal customer while we continue making you happy

Please follow med tech solutions Instagram and share with friends

Official Instagram page
Med_tech_solutions_
👤
FLbodybuilder
Posts: 1,336
Joined: Feb 2015
Rep: 10
👤
FLbodybuilder
1,336 posts · joined Feb 2015
#4
Triple agonism of GLP-1, GIP, and glucagon receptor is a genuinely novel mechanism. The clinical trial data shows fat loss superior to semaglutide with better lean mass preservation due to the glucagon component increasing energy expenditure. For those who can obtain it, the fat loss applications are real.
👤
Dubdoyle
Junior Member
Posts: 12
Joined: May 2015
Rep: 10
👤
Dubdoyle
12 posts · joined May 2015
#5
DarrenW29 wrote:Yes please direct message me


Hi Darren, I’m unsure how to direct message? Could you please contact me with any help you can give? Be very much appreciated. Thank you
👤
Mick AU
Posts: 463
Joined: Aug 2017
Rep: 10
👤
Mick AU
463 posts · joined Aug 2017
#6
The peptide market has changed dramatically in the last few years. For contest prep in the final 8 weeks the fat mobilisation from triple agonists could genuinely replace clen and T3 stacking. The muscle sparing effect is real.
👤
BERLINER
Posts: 516
Joined: Sep 2016
Rep: 10
👤
BERLINER
516 posts · joined Sep 2016
#7
Phase 2 data: Retatrutide at 12mg weekly showed 24.2% body weight reduction over 36 weeks in obese subjects. The glucagon receptor agonism component drives energy expenditure beyond what GLP-1 and GIP alone achieves. For a lean performance athlete the application is acute pre-competition fat loss phases only.
👤
Dutchman
Posts: 568
Joined: Apr 2016
Rep: 10
👤
Dutchman
568 posts · joined Apr 2016
#8
The phase 2b SURMOUNT trial data: glucagon receptor agonism provides approximately 8-10% additional weight loss over matched GLP-1 and GIP dual agonism via increased thermogenesis and hepatic glucose output suppression. The concern for muscle-prioritising athletes is the catabolic potential of sustained glucagon elevation. I would use this only in the final 12 weeks before competition with high protein intake maintained.
👤
Beantown Rick
Posts: 552
Joined: Jun 2016
Rep: 10
👤
Beantown Rick
552 posts · joined Jun 2016
#9
The GLP-1 drugs are a real paradigm shift for what is possible with fat loss in older enhanced athletes. I have been watching the retatrutide data carefully. The triple agonist mechanism gives a meaningfully different efficacy profile compared to semaglutide. The guys who will benefit most are older athletes who have accumulated body fat that diet and cardio alone will not shift anymore. Not a shortcut, but a legitimate metabolic tool.
👤
Mick AU
Posts: 463
Joined: Aug 2017
Rep: 10
👤
Mick AU
463 posts · joined Aug 2017
#10
the oz customs situation makes GLP-1 availability unpredictable here but when you get the genuine product the results are real. lost 8kg over 12 weeks on tirzepatide last year. not a replacement for diet and training but as an adjunct tool it is legitimate and the clinical data backs it up
Reply

📦 Move Thread

✂️ Split Thread Here

This post and all following posts will become a new thread.